The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer

por Bishop, Jennifer L., Thaper, Daksh, Zoubeidi, Amina
Publicado 2014

Immune evasion strategies of neuroendocrine-like Enzalutamide resistant prostate cancer

por Bishop, Jennifer L, Sangha, Barinder, Gleave, Martin, Zoubeidi, Amina
Publicado 2013

Molecular chaperone Hsp27 regulates the Hippo tumor suppressor pathway in cancer

por Vahid, Sepideh, Thaper, Daksh, Gibson, Kate F., Bishop, Jennifer L., Zoubeidi, Amina
Publicado 2016

Galiellalactone inhibits the STAT3/AR signaling axis and suppresses Enzalutamide-resistant Prostate Cancer

por Thaper, Daksh, Vahid, Sepideh, Kaur, Ramandeep, Kumar, Sahil, Nouruzi, Shaghayegh, Bishop, Jennifer L., Johansson, Martin, Zoubeidi, Amina
Publicado 2018

PD-L1 is highly expressed in Enzalutamide resistant prostate cancer

por Bishop, Jennifer L., Sio, Alexander, Angeles, Arkhjamil, Roberts, Morgan E., Azad, Arun A., Chi, Kim N., Zoubeidi, Amina
Publicado 2014

Inhibition of the HER2-YB1-AR axis with Lapatinib synergistically enhances Enzalutamide anti-tumor efficacy in castration resistant prostate cancer

por Shiota, Masaki, Bishop, Jennifer L., Takeuchi, Ario, Nip, Ka Mun, Cordonnier, Thomas, Beraldi, Eliana, Kuruma, Hidetoshi, Gleave, Martin E., Zoubeidi, Amina
Publicado 2015